Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Share-based Compensation: 2016-2024

Historic Share-based Compensation for Arcus Biosciences (RCUS) over the last 9 years, with Dec 2024 value amounting to $76.0 million.

  • Arcus Biosciences' Share-based Compensation fell 26.32% to $14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.0 million, marking a year-over-year decrease of 19.48%. This contributed to the annual value of $76.0 million for FY2024, which is 4.11% up from last year.
  • As of FY2024, Arcus Biosciences' Share-based Compensation stood at $76.0 million, which was up 4.11% from $73.0 million recorded in FY2023.
  • Arcus Biosciences' Share-based Compensation's 5-year high stood at $76.0 million during FY2024, with a 5-year trough of $22.0 million in FY2020.
  • In the last 3 years, Arcus Biosciences' Share-based Compensation had a median value of $73.0 million in 2023 and averaged $71.3 million.
  • Data for Arcus Biosciences' Share-based Compensation shows a peak YoY skyrocketed of 150.00% (in 2021) over the last 5 years.
  • Arcus Biosciences' Share-based Compensation (Yearly) stood at $22.0 million in 2020, then spiked by 150.00% to $55.0 million in 2021, then increased by 18.18% to $65.0 million in 2022, then increased by 12.31% to $73.0 million in 2023, then increased by 4.11% to $76.0 million in 2024.